A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers
A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers
Objective: Pathological gambling is associated with elevated proportions of nicotine dependence, and tobacco smoking in pathological gamblers has been associated with increased problem-gambling severity. This study examined the addition of N-acetylcysteine to imaginal desensitization in adults with co-occurring nicotine dependence and pathological gambling. Method: Twenty-eight individuals with cooccurring DSM-IV nicotine dependence and pathological gambling who were receiving behavioral therapy were recruited from December 2009 to February 2012 and randomized to augmentation with N-acetylcysteine or placebo in an 12-week, double-blind trial. Subjects were assessed with measures of nicotine and gambling severity and followed for 3 months after treatment. The primary outcomes were the Fagerström Test for Nicotine Dependence and the pathological gambling adaptation of the Yale- Brown Obsessive-Compulsive Scale. Results: During the first 6 weeks, there was a significant benefit of N-acetylcysteine treatment versus placebo on Fagerström Test for Nicotine Dependence total scores (t = -2.224; P = .031). After the initial 6 weeks, all subjects significantly (P < .001) benefited from imaginal desensitization. During the 3-month follow-up, there was a significant additional benefit for N-acetylcysteine versus placebo on measures of problem-gambling severity (t = 2.069; P = .043). Conclusions: N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed.
39-45
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Odlaug, Brian L.
f021d299-d250-44a2-bb17-6f7e16bfa0f6
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Potenza, Marc N.
4331dcd8-d078-437b-a202-85b02faf9d56
Schreiber, Liana R.N.
5d659814-23de-4dec-b9d4-5341ad99738b
Donahue, Christopher B.
99aedc69-21f4-4705-988a-a54cdebfa82a
Kim, Suck Won
9fe9fcb5-3b23-4c3d-9bb9-4e1ef88965f2
January 2014
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Odlaug, Brian L.
f021d299-d250-44a2-bb17-6f7e16bfa0f6
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Potenza, Marc N.
4331dcd8-d078-437b-a202-85b02faf9d56
Schreiber, Liana R.N.
5d659814-23de-4dec-b9d4-5341ad99738b
Donahue, Christopher B.
99aedc69-21f4-4705-988a-a54cdebfa82a
Kim, Suck Won
9fe9fcb5-3b23-4c3d-9bb9-4e1ef88965f2
Grant, Jon E., Odlaug, Brian L., Chamberlain, Samuel R., Potenza, Marc N., Schreiber, Liana R.N., Donahue, Christopher B. and Kim, Suck Won
(2014)
A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers.
Journal of Clinical Psychiatry, 75 (1), .
(doi:10.4088/JCP.13m08411).
Abstract
Objective: Pathological gambling is associated with elevated proportions of nicotine dependence, and tobacco smoking in pathological gamblers has been associated with increased problem-gambling severity. This study examined the addition of N-acetylcysteine to imaginal desensitization in adults with co-occurring nicotine dependence and pathological gambling. Method: Twenty-eight individuals with cooccurring DSM-IV nicotine dependence and pathological gambling who were receiving behavioral therapy were recruited from December 2009 to February 2012 and randomized to augmentation with N-acetylcysteine or placebo in an 12-week, double-blind trial. Subjects were assessed with measures of nicotine and gambling severity and followed for 3 months after treatment. The primary outcomes were the Fagerström Test for Nicotine Dependence and the pathological gambling adaptation of the Yale- Brown Obsessive-Compulsive Scale. Results: During the first 6 weeks, there was a significant benefit of N-acetylcysteine treatment versus placebo on Fagerström Test for Nicotine Dependence total scores (t = -2.224; P = .031). After the initial 6 weeks, all subjects significantly (P < .001) benefited from imaginal desensitization. During the 3-month follow-up, there was a significant additional benefit for N-acetylcysteine versus placebo on measures of problem-gambling severity (t = 2.069; P = .043). Conclusions: N-acetylcysteine treatment during therapy facilitates long-term application of behavioral therapy techniques once patients are in the community after therapy has been completed.
This record has no associated files available for download.
More information
Published date: January 2014
Identifiers
Local EPrints ID: 493102
URI: http://eprints.soton.ac.uk/id/eprint/493102
ISSN: 0160-6689
PURE UUID: 17b11245-a89d-44d6-8485-4cd20749f416
Catalogue record
Date deposited: 22 Aug 2024 17:21
Last modified: 23 Aug 2024 01:59
Export record
Altmetrics
Contributors
Author:
Jon E. Grant
Author:
Brian L. Odlaug
Author:
Samuel R. Chamberlain
Author:
Marc N. Potenza
Author:
Liana R.N. Schreiber
Author:
Christopher B. Donahue
Author:
Suck Won Kim
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics